Read the full article here.
This content was originally published by Inc Magazine. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Inc Magazine
Synthetic gene manufacturer ATUM turned down venture capital. That's why it's free to do whatever it takes to fight Covid-19.